Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown125%
enrolling_by_invitation125%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
completed

Arm Exercise Capacity and Maximal Oxygen Consumption With Breast Cancer

NCT06018038
completednot_applicable

Muscle Oxygenation in Effort in Neuromuscular Diseases

NCT02789059
enrolling_by_invitationnot_applicable

The Effect of Peak Force At Long and Short Muscle Lengths and the Impact on Muscle Growth and Strength

NCT06666127
unknown

Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis

NCT03902236

Clinical Trials (4)

Showing 4 of 4 trials
NCT06018038

Arm Exercise Capacity and Maximal Oxygen Consumption With Breast Cancer

Completed
NCT02789059Not Applicable

Muscle Oxygenation in Effort in Neuromuscular Diseases

Completed
NCT06666127Not Applicable

The Effect of Peak Force At Long and Short Muscle Lengths and the Impact on Muscle Growth and Strength

Enrolling By Invitation
NCT03902236

Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4